Circular Dichroism and Peptide Secondary Structure

Run a typical short synthetic peptide in plain aqueous buffer and the trace that comes back is a deep negative band near 198 nanometers with essentially nothing else on it. That is the disordered signature, and it is the honest answer rather than a fault in the material. A chain needs something like three to four helical turns before the geometry holds together against thermal motion, and most short sequences simply do not have enough chain to hold any shape at all.

Understanding why that trace looks the way it does means understanding what the measurement is for. Composition is not the question here. Mass, residue order and target content all belong to other methods. This one asks what shape the chain is currently occupying in the solution it happens to be sitting in.

What the instrument is actually detecting

Left-handed and right-handed circularly polarized light are absorbed unequally by any molecule assembled from chiral units. Plot that difference in absorbance across wavelength and you have the spectrum. Since a peptide backbone consists of chiral centers arranged in repeating geometry, both the sign and the magnitude of the difference track that geometry, which is precisely what secondary structure means.

One consequence is worth keeping in view: a racemic mixture produces no signal whatsoever, the enantiomers cancelling each other out. The technique exists because peptides are chiral, and it responds directly to stereochemical change of the sort described under racemization and chiral purity.

Reference signatures

Three shapes account for most of what turns up.

Nothing observed is ever purely one of these. Deconvolution software fits the measured curve as a weighted combination of reference spectra and hands back percentages, but a percentage produced this way is the output of a fit rather than a measured quantity. Two mixtures that differ structurally can produce the same curve and therefore the same numbers.

Two windows in the ultraviolet

Roughly 190 to 250 nanometers is the far-ultraviolet window, where the absorbing group is the backbone amide. Secondary structure lives here, and virtually every peptide measurement uses this region. Above it, from roughly 250 to 320 nanometers, the near ultraviolet reports on aromatic side chains and any disulfide bonds, describing the environment those groups occupy. That makes it a tertiary structure probe, which for a short peptide is close to useless: there is no tertiary structure for it to describe. The near-ultraviolet window also demands considerably more material, its aromatic signals being an order of magnitude weaker than the backbone ones.

Everything is a population average

Here is the limitation that matters most and gets overlooked most reliably. What reaches the detector is the sum over every molecule in the cuvette. Call a sample thirty percent helical and you may mean that thirty percent of the chains are fully helical while seventy percent are disordered, or that every chain is helical across thirty percent of its length, or any arrangement between those. The spectrum cannot distinguish them.

It also carries no positional information. Which residues are structured is a question for nuclear magnetic resonance or crystallography, and in practice for neither, since neither is typically run on a synthetic peptide.

Cuvette conditions that decide whether a spectrum exists

Far-ultraviolet work tolerates very little company, because anything absorbing in that window lifts the noise floor until the signal vanishes beneath it. Chloride is the classic offender, absorbing strongly below 200 nanometers, which is why low-concentration phosphate or fluoride buffers get substituted. Trifluoroacetate absorbs in the same region, so a peptide supplied as the trifluoroacetate salt arrives with a counter-ion that interferes with its own structural measurement; that is one of the practical arguments for salt exchange, and the full trade-off appears under counter-ions and salt form.

Two further requirements are easy to underestimate. Concentration has to be known accurately, since the reported quantity is normalized per residue and any concentration error propagates straight through into the stated helix content. Determination of the kind described in concentration by A280 is therefore part of the measurement, not a preliminary to it. And aggregates scatter light, distorting the baseline. A spectrum taken from a hazy solution is not a structural result; whatever produces the haze is treated in peptide aggregation in solution.

Reading a thermal transition

Hold the instrument at a single wavelength, conventionally 222 nanometers, raise the temperature, and the signal decays as structure is lost. Whoever reports the midpoint of that decay calls it an apparent melting temperature.

Apparent carries the weight in that phrase. The figure describes this peptide in this buffer at this concentration rather than any constant belonging to the molecule, and it only functions as a thermodynamic quantity when the transition reverses on cooling. Plenty of peptides aggregate when heated instead of unfolding cleanly, producing an irreversible curve whose midpoint marks the onset of aggregation, not the middle of an unfolding event.

Induced structure and what it reports

Structure is often something the conditions supply rather than something the sequence possesses. Add trifluoroethanol, or a membrane-mimetic detergent, and a chain that reads as disordered in buffer will return a helical spectrum. That result describes propensity under the conditions applied, so publishing it without those conditions attached conveys nothing. Fragments that behave this way are common; one is examined in the analysis of the LL-37 cathelicidin fragment.

The questions it cannot answer, and the one it can

This is neither an identity test nor a purity test. A peptide and its deletion sequence will not be told apart by it, residual solvent is invisible to it, and a badly impure sample can still yield a clean spectrum provided the impurities are themselves unstructured.

Its contribution is to a question no chromatogram or mass spectrum can reach, and to reach it independently in the sense laid out in confirming identity with two independent methods: has a correctly assembled chain folded as intended? For most short peptides that question never arises, which explains its absence from routine certificates. It becomes worth asking for disulfide-constrained and longer chains, where correct mass and correct connectivity still leave folding unresolved, the situation described in where peptide analysis becomes protein analysis.